CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure. (Q37911729)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 August 2011

Language	Label	Description	Also known as
English	CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure.	scientific article published on 03 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failure (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1

object named as

John J V McMurray

1 reference

Europe PubMed Central

25 August 2017

publication date

3 August 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

European Journal of Heart Failure

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

929-936

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Reconsidering the roles of the mineralocorticoid receptor

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effect of carvedilol on survival in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

HEAAL: the final chapter in the story of angiotensin receptor blockers in heart failure--lessons learnt from a decade of trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Telmisartan, ramipril, or both in patients at high risk for vascular events

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Eplerenone in patients with systolic heart failure and mild symptoms

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

EURObservational Research Programme: the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

European Society of Cardiology Heart Failure Association Standards for delivering heart failure care

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT).

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Irbesartan in patients with heart failure and preserved ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFR093

21 January 2018

Identifiers

10.1093/EURJHF/HFR093

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21816763%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37911729&oldid=1577084989"